Literature DB >> 16236389

[Renal involvement in ankylosing spondylitis: concerning 210 cases].

C Ben Taarit1, H Ajlani, F Ben Moussa, T Ben Abdallah, H Ben Maïz, A Khedher.   

Abstract

PURPOSE: To define the epidemiology, clinical, biological and histological features of renal diseases in ankylosing spondylitis, ginving special attention to unusual forms.
METHODS: We retrospectively reviewed the medical record of 28 cases with renal involvement among 210 cases of ankylosing spondylitis seen over a 27 year period who met the Amor criteria.
RESULTS: Twenty-eight of 210 patients (13,3%) presented one or more signs of renal involvement: macroscopic hematuria (4 patients), microscopic hematuria (8 patients), proteinuria (15 patients), nephrotic syndrome (6 patients), decreased renal function (13 patients). Secondary renal amyloidosis and nephrolithiasis (8 patients) were the most common cause of renal involvement in ankylosing spondylitis followed by IgA nephropathy (3 patients).
CONCLUSION: The funding of renal abnormalities in 13,3% of our patients suggests that in this illness evidence of renal involvement should be actively investigated in ankylosing spondylitis.

Entities:  

Mesh:

Year:  2005        PMID: 16236389     DOI: 10.1016/j.revmed.2005.07.017

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  7 in total

1.  A case report on nephrotic syndrome associated with ankylosing spondylitis effectively treated with infliximab.

Authors:  Xin Feng; Yao Li; Wei Gao
Journal:  Int J Clin Exp Med       Date:  2014-09-15

2.  Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization.

Authors:  Soeren A Peters; Aydan Yazar; Stefan P Lemburg; Christoph M Heyer
Journal:  Int J Cardiovasc Imaging       Date:  2007-02-07       Impact factor: 2.357

3.  Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease.

Authors:  Alessandro Giollo; Andrea Dalbeni; Giovanni Cioffi; Federica Ognibeni; Davide Gatti; Luca Idolazzi; Giovanni Orsolini; Pietro Minuz; Maurizio Rossini; Cristiano Fava; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2017-09-09       Impact factor: 2.980

4.  Spectrums and Prognosis of Kidney Disease in Patients with Ankylosing Spondylitis.

Authors:  Dafeng He; Rong Wang; Shaoshan Liang; Dandan Liang; Feng Xu; Caihong Zeng; Zheng Tang
Journal:  Kidney Dis (Basel)       Date:  2020-08-26

5.  MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: A meta-analysis.

Authors:  Linqing Zhong; Hongmei Song; Wei Wang; Ji Li; Mingsheng Ma
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

6.  Axial Spondyloarthritis and Autosomal Dominant Polycystic Kidney Disease in Two Siblings: A Rare Cooccurrence.

Authors:  Ozan Volkan Yurdakul; Abdulkerim Furkan Tamer; Okan Küçükakkaş; Aylin Rezvani
Journal:  Case Rep Rheumatol       Date:  2018-03-04

7.  Gender and chronic kidney disease in ankylosing spondylitis: a single-center retrospectively study.

Authors:  Wenling Ye; Jing Zhuang; Yang Yu; Hang Li; Xiaomei Leng; Jun Qian; Yan Qin; Limeng Chen; Xue-Mei Li
Journal:  BMC Nephrol       Date:  2019-12-09       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.